These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21191418)

  • 1. The Th2 systemic immune milieu enhances cutaneous inflammation in the K14-IL-4-transgenic atopic dermatitis model.
    Reichle ME; Chen L; Lin SX; Chan LS
    J Invest Dermatol; 2011 Mar; 131(3):791-4. PubMed ID: 21191418
    [No Abstract]   [Full Text] [Related]  

  • 2. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
    Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
    J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
    Chen L; Overbergh L; Mathieu C; Chan LS
    Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
    Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
    Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells.
    Mori T; Kabashima K; Fukamachi S; Kuroda E; Sakabe J; Kobayashi M; Nakajima S; Nakano K; Tanaka Y; Matsushita S; Nakamura M; Tokura Y
    J Dermatol Sci; 2013 Jul; 71(1):37-44. PubMed ID: 23639699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periostin promotes chronic allergic inflammation in response to Th2 cytokines.
    Masuoka M; Shiraishi H; Ohta S; Suzuki S; Arima K; Aoki S; Toda S; Inagaki N; Kurihara Y; Hayashida S; Takeuchi S; Koike K; Ono J; Noshiro H; Furue M; Conway SJ; Narisawa Y; Izuhara K
    J Clin Invest; 2012 Jul; 122(7):2590-600. PubMed ID: 22684102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerogenic antigen-presenting cells successfully inhibit atopic dermatitis-like skin lesion induced by repeated epicutaneous exposure to ovalbumin.
    Katagiri K; Arakawa S; Hatano Y; Fujiwara S
    Arch Dermatol Res; 2008 Nov; 300(10):583-93. PubMed ID: 18528699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: possible shift from a Th2- to Th1-predominance.
    Horiuchi Y; Bae S; Katayama I; Nishioka K
    J Dermatol Sci; 2004 Sep; 35(3):187-97. PubMed ID: 15381240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous atopic dermatitis-like symptoms in a/a ma ft/ma ft/J flaky tail mice appear early after birth.
    Kypriotou M; Boéchat C; Huber M; Hohl D
    PLoS One; 2013; 8(7):e67869. PubMed ID: 23844115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxp3+ cells control Th2 responses in a murine model of atopic dermatitis.
    Fyhrquist N; Lehtimäki S; Lahl K; Savinko T; Lappeteläinen AM; Sparwasser T; Wolff H; Lauerma A; Alenius H
    J Invest Dermatol; 2012 Jun; 132(6):1672-80. PubMed ID: 22402436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR4 Is Critically Involved in Skin Allergic Inflammation of BALB/c Mice.
    Matsuo K; Nagakubo D; Komori Y; Fujisato S; Takeda N; Kitamatsu M; Nishiwaki K; Quan YS; Kamiyama F; Oiso N; Kawada A; Yoshie O; Nakayama T
    J Invest Dermatol; 2018 Aug; 138(8):1764-1773. PubMed ID: 29510192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant interleukin-4/13 signaling blockade successfully suppresses acute phase inflammation.
    Nakanishi T; Yamanaka K; Kakeda M; Tsuda K; Mizutani H
    Arch Dermatol Res; 2013 Apr; 305(3):241-7. PubMed ID: 23179586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basophils are important for development of allergic skin inflammation.
    Leyva-Castillo JM; Vega-Mendoza D; Strakosha M; Deng L; Choi S; Miyake K; Karasuyama H; Chiu IM; Phipatanakul W; Geha RS
    J Allergy Clin Immunol; 2024 May; 153(5):1344-1354.e5. PubMed ID: 38336257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-21 comes of age.
    Foster PS; Mattes J
    Immunol Cell Biol; 2009 Jul; 87(5):359-60. PubMed ID: 19399026
    [No Abstract]   [Full Text] [Related]  

  • 15. Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β.
    Schwartz C; Moran T; Saunders SP; Kaszlikowska A; Floudas A; Bom J; Nunez G; Iwakura Y; O'Neill L; Irvine AD; McKenzie ANJ; Ogg G; Walsh PT; Demengeot J; Fallon PG
    Allergy; 2019 Oct; 74(10):1920-1933. PubMed ID: 30937919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis.
    Mashiko S; Mehta H; Bissonnette R; Sarfati M
    J Dermatol Sci; 2017 Nov; 88(2):167-174. PubMed ID: 28743611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization.
    Laouini D; Elkhal A; Yalcindag A; Kawamoto S; Oettgen H; Geha RS
    J Allergy Clin Immunol; 2005 Aug; 116(2):390-6. PubMed ID: 16083795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of IL-4 alters the homeostasis in the skin.
    Elbe-Bürger A; Egyed A; Olt S; Klubal R; Mann U; Rappersberger K; Rot A; Stingl G
    J Invest Dermatol; 2002 May; 118(5):767-78. PubMed ID: 11982753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice.
    Tenda Y; Yamashita M; Kimura MY; Hasegawa A; Shimizu C; Kitajima M; Onodera A; Suzuki A; Seki N; Nakayama T
    J Allergy Clin Immunol; 2006 Sep; 118(3):725-33. PubMed ID: 16950294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine receptor CCR3 participates in tissue remodeling during atopic skin inflammation.
    Gaspar K; Kukova G; Bunemann E; Buhren BA; Sonkoly E; Szollosi AG; Muller A; Savinko T; Lauerma AI; Alenius H; Kemeny L; Dieu-Nosjean MC; Stander S; Fischer JW; Ruzicka T; Zlotnik A; Szegedi A; Homey B
    J Dermatol Sci; 2013 Jul; 71(1):12-21. PubMed ID: 23702389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.